摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-((4-methoxyphenyl)ethynyl)aniline | 1182977-32-7

中文名称
——
中文别名
——
英文名称
3-((4-methoxyphenyl)ethynyl)aniline
英文别名
1-methoxy-4-(3-aminophenylethynyl)benzene;3-(4-Methoxy-phenylethynyl)-phenylamine;3-[2-(4-methoxyphenyl)ethynyl]aniline
3-((4-methoxyphenyl)ethynyl)aniline化学式
CAS
1182977-32-7
化学式
C15H13NO
mdl
——
分子量
223.274
InChiKey
VCTOWTCEALJPRO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    412.0±30.0 °C(Predicted)
  • 密度:
    1.16±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-((4-methoxyphenyl)ethynyl)aniline4-aminobenzamidine dihydrochloride盐酸 、 sodium nitrite 作用下, 以 为溶剂, 反应 0.5h, 以31%的产率得到(E)-4-(3-(3-((4-methoxyphenyl)ethynyl)phenyl)triaz-1-enyl)benzimidamide
    参考文献:
    名称:
    Alkyne-substituted diminazene as G-quadruplex binders with anticancer activities
    摘要:
    G-quadruplex ligands have been touted as potential anticancer agents, however, none of the reported G-quadruplex-interactive small molecules have gone past phase II clinical trials. Recently it was revealed that diminazene (berenil, DMZ) actually binds to G-quadruplexes 1000 times better than DNA duplexes, with dissociation constants approaching 1 nM. DMZ however does not have strong anticancer activities. In this paper, using a panel of biophysical tools, including NMR, FRET melting assay and FRET competition assay, we discovered that monoamidine analogues of DMZ bearing alkyne substitutes selectively bind to G-quadruplexes. The lead DMZ analogues were shown to be able to target c-MYC G-quadruplex both in vitro and in vivo. Alkyne DMZ analogues display respectable anticancer activities (single digit micromolar GI(50)) against ovarian (OVCAR-3), prostate (PC-3) and triple negative breast (MDA-MB-231) cancer cell lines and represent interesting new leads to develop anticancer agents. (C) 2016 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2016.04.030
  • 作为产物:
    描述:
    4-碘苯甲醚3-氨基苯乙炔tris-(dibenzylideneacetone)dipalladium(0) 、 potassium phosphate tribasic heptahydrate 作用下, 以 乙醇 为溶剂, 反应 1.5h, 以95%的产率得到3-((4-methoxyphenyl)ethynyl)aniline
    参考文献:
    名称:
    在水性介质中钯催化的膦、无铜和有氧 Sonogashira 偶联
    摘要:
    在水性、无铜和有氧条件下,使用 Pd2(dba)3(dba=二亚苄基丙酮)作为催化剂,开发了一种简单、高效且不含膦的方案,用于芳基碘化物与末端炔烃的 Sonogashira 偶联。芳基碘化物与芳族末端炔烃的偶联提供了良好到极好的产率,并且使用脂族末端炔烃作为偶联伙伴之一实现了中等至良好的产率。根据绿色化学的概念,乙醇水溶液作为溶剂经济且环保。
    DOI:
    10.3998/ark.5550190.0012.b06
点击查看最新优质反应信息

文献信息

  • Synthesis and characterization of recyclable and recoverable MMT-clay exchanged ammonium tagged carbapalladacycle catalyst for Mizoroki–Heck and Sonogashira reactions in ionic liquid media
    作者:Vasundhara Singh、Rajni Ratti、Sukhbir Kaur
    DOI:10.1016/j.molcata.2010.10.015
    日期:2011.1
    carbapalladacycle 5 assists in the pillaring process and enhances the organophilicity of catalyst 6 in the interlayers of clay. The catalytic activity in ammonium based ionic liquid [TMBA] NTf2 of both the homogeneous and heterogeneous recyclable catalysts 5 and 6 respectively in micromolar concentration of palladium has been tested for Mizoroki–Heck and Sonogashira reactions in good yields with high TON/TOF and
    已经实现了以适度的产率高效合成铵标记的咔哒哒哒啉5。此外,通过将5离子交换成粘土夹层作为新的有机-无机杂化催化体系,可以制备粘土-纳米复合材料6。铵负载的咔唑四环素5的离子标签有助于柱化过程,并增强了粘土中间层中催化剂6的亲有机性。均相和非均相可循环催化剂5和6在铵基离子液体[TMBA] NTf 2中的催化活性已经测试了分别以微摩尔浓度的钯进行Mizoroki-Heck和Sonogashira反应的高产率,高TON / TOF和可忽略不计的金属浸出。还研究了溶剂和温度对催化活性的影响。
  • Functionalized α,β-ynones: efficient ligand for Cu catalyzed Sonogashira-type cross-coupling reaction
    作者:Xian Wang、Zhenhua Wang、Zunyuan Xie、Guofang Zhang、Weiqiang Zhang、Ziwei Gao
    DOI:10.1039/c6ra23742h
    日期:——
    donor ligands were mandatory for the catalytic cross-coupling of Csp2–Csp bonds. Herein, we wish to report α,β-ynones as σ-, π-electron donating ligands for copper catalyzed Sonogashira-type reaction. As low as 0.25–2.5 mol% of L11 (3-(4-bromophenyl)-1-(4-methoxyphenyl)prop-2-yn-1-one) significantly accelerated the 0.1–1.0 mol% of CuI catalyzed cross-coupling of aryl iodides with terminal alkynes and
    在经典的反应条件下,大量的铜催化剂和N,O供体配体对于Csp 2 -Csp键的催化交叉偶联是必需的。在此,我们希望报道α,β-炔酮作为铜催化的Sonogashira型反应的σ-,π-电子给体。低至0.25–2.5 mol%的L 11(3-(4-溴苯基)-1-(4-甲氧基苯基)prop-2-yn-1-one)显着加速了0.1–1.0 mol%的CuI催化的交叉芳基碘化物分别与末端炔烃和炔基羧酸偶联。这种低摩尔%的催化剂体系具有36个取代炔烃实例,显示出令人满意的活性和耐受性。
  • Cu/Oxalic Diamide-Catalyzed Coupling of Terminal Alkynes with Aryl Halides
    作者:Ying Chen、Sailuo Li、Lanting Xu、Dawei Ma
    DOI:10.1021/acs.joc.2c02882
    日期:2023.3.3
    6-Dimethylphenyl)-N2-(pyridin-2-ylmethyl)oxalamide (DMPPO) was revealed to be a more effective ligand for copper-catalyzed coupling reaction of (hetero)aryl halides with 1-alkynes than previously reported ones. Only 3 mol % CuCl and DMPPO are required to make the coupling complete at 100 °C (for bromides) and 80 °C (for iodides). Both (hetero)aryl and alkyl substituted 1-alkynes worked well under these conditions
    N 1 -(2,6-二甲基苯基)- N 2 -(吡啶-2-基甲基)草酰胺 (DMPPO) 被发现是铜催化的(杂)芳基卤化物与 1-炔烃偶联反应的更有效配体以前报道过的。仅需 3 mol% CuCl 和 DMPPO 即可在 100 °C(溴化物)和 80 °C(碘化物)下完成偶联。(杂)芳基和烷基取代的 1-炔烃在这些条件下都表现良好,导致内部炔烃的形成具有很大的多样性。
  • LINKED DIARYL COMPOUNDS WITH ANTICANCER PROPERTIES AND METHODS OF USING THE SAME
    申请人:University of Maryland, College Park
    公开号:US20170174620A1
    公开(公告)日:2017-06-22
    Provided are compositions comprising linked diaryl compounds that possess anticancer properties. Methods of use are also disclosed herein. The method comprises administering an effective amount of a compound described herein to an individual in need thereof.
  • [EN] LINKED DIARYL COMPOUNDS WITH ANTICANCER PROPERTIES AND METHODS OF USING THE SAME<br/>[FR] COMPOSÉS BIARYLES LIÉS À PROPRIÉTÉS ANTICANCÉREUSES ET LEURS PROCÉDÉS D'UTILISATION
    申请人:UNIV MARYLAND
    公开号:WO2016014674A1
    公开(公告)日:2016-01-28
    Provided are compositions comprising linked diaryl compounds that possess anticancer properties. Methods of use are also disclosed herein. The method comprises administering an effective amount of a compound described herein to an individual in need thereof.
查看更多